These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1890350)

  • 21. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
    Kysela B; Siracký J; Redecha M; Bárdos A
    Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
    Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
    Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flow cytometric DNA content analysis in thyroid carcinoma].
    Zuo LF
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
    Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
    Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
    Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
    Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell cycle in patients with stage I endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
    Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of uterine sarcomas.
    Lennart K; Lennart B; Ulf S; Bernard T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
    Johnson TS; Williamson KD; Cramer MM; Peters LJ
    Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA flow cytometry in uterine endometrial carcinoma.
    Jacobsen M; Høyer M; Bentzen SM; Nielsen K
    APMIS Suppl; 1991; 23():107-12. PubMed ID: 1883634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of endometrial cancer by DNA cytophotometry].
    Dietl J; Hedderich J; Sprenger E
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):796-9. PubMed ID: 3803873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric analysis of human uterine sarcomas and cell lines.
    Nelson KG; Haskill JS; Sloan S; Siegfried JM; Siegal GP; Walton L; Kaufman DG
    Cancer Res; 1987 Jun; 47(11):2814-20. PubMed ID: 3567904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.